The impact of early de novo donor-specific antibodies on lung transplant outcomes: Is timing everything?

被引:1
|
作者
King, Christopher S. [1 ]
Cochrane, Adam B. [2 ]
机构
[1] Inova Fairfax Hosp, Adv Lung Dis & Lung Transplant Clin, 618 S Royal St, Falls Church, VA 22314 USA
[2] Inova Fairfax Hosp, Adv Lung Dis Clin, Dept Pharm, Falls Church, VA USA
来源
关键词
BRONCHIOLITIS OBLITERANS SYNDROME; MEDIATED REJECTION; INTERNATIONAL SOCIETY; HLA-ANTIBODIES; HEART;
D O I
10.1016/j.healun.2016.07.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1057 / 1058
页数:2
相关论文
共 50 条
  • [21] Outcomes of De Novo Donor Specific Antibodies in Pancreas Transplant Recipients.
    Parajuli, S.
    Alagusundaramoorthy, S.
    Aziz, F.
    Garg, N.
    Redfield, R.
    Sollinger, H.
    Kaufman, D.
    Djamali, A.
    Odorico, J.
    Mandelbrot, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 432 - 432
  • [22] Outcomes in Kidney Transplant Recipients That Develop De Novo Donor Specific Antibodies
    DeVos, J. M.
    Patel, S. J.
    Land, G.
    Knight, R. J.
    Achkar, K.
    Dilioglou, S.
    Dawson, K. L.
    Abdellatif, A.
    Gaber, A. O.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 294 - 294
  • [23] Presence of de Novo Donor-Specific Antibodies to HLA-DQ in Lung Transplant Recipients Predicts Poor Survival
    Belloli, E. A.
    Fitzgerald, L.
    Lyu, D.
    Moussa, O.
    Chan, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S442 - S443
  • [24] Development and outcomes of de novo donor-specific antibodies in low, moderate, and high immunological risk kidney transplant recipients
    Wan, Susan S.
    Chadban, Steven J.
    Watson, Narelle
    Wyburn, Kate
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 (05) : 1351 - 1364
  • [25] Renal transplant outcomes and de novo donor-specific anti-human leukocyte antigen antibodies: a systematic review
    Sharma, Ankit
    Lewis, Joshua R.
    Lim, Wai H.
    Palmer, Suetonia
    Strippoli, Giovanni
    Chapman, Jeremy R.
    Alexander, Stephen I.
    Craig, Jonathan C.
    Wong, Germaine
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (08) : 1472 - 1480
  • [26] De Novo Donor-Specific Antibodies After Allograft Nephrectomy
    Lucisano, G.
    Brookes, P.
    Santos-Nunez, E.
    Firmin, N.
    Gunby, N.
    Hassan, S.
    Gueret-Wardle, A.
    Willicombe, M.
    Taube, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 222 - 223
  • [27] DE NOVO DONOR-SPECIFIC HLA ANTIBODIES IN LOW RISK PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Yilmaz, Alev
    Oguz, Fatma Savran
    Usta, Sebahat
    Yildirim, Zeynep Yuruk
    Pehlivanoglu, Cemile
    Kekik, Cigdem
    Emre, Sevinc
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1724 - 1724
  • [28] Microcirculation Inflammation Associates With Outcome in Renal Transplant Patients With De Novo Donor-Specific Antibodies
    de Kort, H.
    Willicombe, M.
    Brookes, P.
    Dominy, K. M.
    Santos-Nunez, E.
    Galliford, J. W.
    Chan, K.
    Taube, D.
    McLean, A. G.
    Cook, H. T.
    Roufosse, C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (02) : 485 - 492
  • [29] DE NOVO DONOR-SPECIFIC HLA ANTIBODIES IN LOW RISK PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
    Yilmaz, A.
    Yildirim, Z. Yuruk
    Pehlivanoglu, C.
    Nayir, A.
    Emre, S.
    Savran, F. Oguz
    Usta, S.
    Kekik, C.
    PEDIATRIC TRANSPLANTATION, 2015, 19 : 125 - 125
  • [30] Prevalence and Impact of Donor-Specific Antibodies in Liver Transplant
    Taner, T.
    Schuyler, S.
    Cornell, L.
    Gandhi, M.
    Stegall, M.
    Heimbach, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 185 - 185